13D/13G Filings - Biodexa Pharmaceuticals Plc (BDRX)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-05-28
5:59 pm
Purchase
2025-05-2013GBiodexa Pharmaceuticals Plc
BDRX
Cavalry Fund I LP175,239,000
6.800%
175,239,000increase
(New Position)
Filing
History
2025-02-18
4:30 pm
Unchanged
2025-02-1013GBiodexa Pharmaceuticals Plc
BDRX
Cavalry Fund I LP0
0.000%
0
(Unchanged)
Filing
History
2024-11-20
11:56 am
Purchase
2024-11-1413GBiodexa Pharmaceuticals Plc
BDRX
Brio Capital Master Fund Ltd.16,768
0.900%
11,057increase
(+193.59%)
Filing
History
2024-11-14
5:12 pm
Sale
2024-09-3013GBiodexa Pharmaceuticals Plc
BDRX
Iroquois Capital Management, LLC11,208
0.670%
-4,471,896decrease
(-99.75%)
Filing
History
2024-11-12
4:30 pm
Purchase
2024-09-3013GBiodexa Pharmaceuticals Plc
BDRX
Bigger Capital LLC6,926,080
11.000%
5,959,542increase
(+616.59%)
Filing
History
2024-11-07
4:51 pm
Sale
2024-09-3013GBiodexa Pharmaceuticals Plc
BDRX
Cavalry Fund I LP0
0.000%
-464,781decrease
(Position Closed)
Filing
History
2024-08-08
4:24 pm
Purchase
2024-07-1913GBiodexa Pharmaceuticals Plc
BDRX
Iroquois Capital Management, LLC4,483,104
9.990%
4,483,104increase
(New Position)
Filing
History
2024-07-23
3:09 pm
Purchase
2024-07-1513GBiodexa Pharmaceuticals Plc
BDRX
Brio Capital Master Fund Ltd.5,711
9.830%
5,711increase
(New Position)
Filing
History
2024-02-14
8:47 pm
Purchase
2023-12-3113GBiodexa Pharmaceuticals Plc
BDRX
Ionic Ventures, LLC542
4.900%
542increase
(New Position)
Filing
History
2024-02-14
2:42 pm
Purchase
2023-12-3113GBiodexa Pharmaceuticals Plc
BDRX
ARMISTICE CAPITAL LLC100
0.940%
100increase
(New Position)
Filing
History
2024-02-14
2:14 pm
Unchanged
2023-12-3113GBiodexa Pharmaceuticals Plc
BDRX
CVI Investments, Inc.0
0.000%
0
(Unchanged)
Filing
History
2024-02-13
4:33 pm
Purchase
2023-12-3113GBiodexa Pharmaceuticals Plc
BDRX
Cavalry Fund I LP464,781
9.900%
22,549increase
(+5.10%)
Filing
History
2024-02-12
4:30 pm
Purchase
2023-12-2113GBiodexa Pharmaceuticals Plc
BDRX
Bigger Capital LLC966,538
9.900%
966,538increase
(New Position)
Filing
History
2024-01-08
4:01 pm
Purchase
2023-12-2113GBiodexa Pharmaceuticals Plc
BDRX
Mercer Street Global Opportunity Fund LLC437,587
9.990%
437,587increase
(New Position)
Filing
History
2023-12-28
4:30 pm
Purchase
2023-12-2113GBiodexa Pharmaceuticals Plc
BDRX
Cavalry Fund I LP442,232
9.900%
442,232increase
(New Position)
Filing
History
2023-03-06
06:01 am
Purchase
2023-02-1513GMidatech Pharma plc
MTP
Ionic Ventures, LLC4,509,231
9.990%
4,509,231increase
(New Position)
Filing
History
2023-02-21
11:10 am
Purchase
2023-02-0913GMidatech Pharma plc
MTP
CVI Investments, Inc.2,708,500
6.200%
2,708,500increase
(New Position)
Filing
History
2023-02-14
1:50 pm
Purchase
2022-12-3113GMidatech Pharma plc
MTP
ARMISTICE CAPITAL LLC96,707
8.930%
96,707increase
(New Position)
Filing
History